103 related articles for article (PubMed ID: 3131591)
21. Influence of antioestrogens on specific binding of [3H]oestradiol in vitro by nuclei from rat mammary tumours.
Powell-Jones W; Davies P; Griffiths K
J Endocrinol; 1975 Sep; 66(3):437-8. PubMed ID: 1194818
[No Abstract] [Full Text] [Related]
22. Estradiol binding to nuclear receptors in human breast cancer tissue (MCF-7 cell line) and in dimethylbenz(a)anthracene-induced mammary carcinoma.
Geier A; Cocos M; Ginzburg R; Haimsohn M; Lunenfeld B
J Clin Endocrinol Metab; 1979 Jul; 49(1):34-9. PubMed ID: 109464
[TBL] [Abstract][Full Text] [Related]
23. Antitumor effects of droloxifene, a new antiestrogen drug, against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
Kawamura I; Mizota T; Kondo N; Shimomura K; Kohsaka M
Jpn J Pharmacol; 1991 Oct; 57(2):215-24. PubMed ID: 1812300
[TBL] [Abstract][Full Text] [Related]
24. Increased DNA binding of the estrogen receptor in an estrogen-resistant mammary cancer.
Baskevitch PP; Vignon F; Bousquet C; Rochefort H
Cancer Res; 1983 May; 43(5):2290-7. PubMed ID: 6403233
[TBL] [Abstract][Full Text] [Related]
25. Studies with steroid-fluorescein conjugates on oestrogen target tissues.
Joyce BG; Nicholson RI; Morton MS; Griffiths K
Eur J Cancer Clin Oncol; 1982 Nov; 18(11):1147-55. PubMed ID: 6819146
[TBL] [Abstract][Full Text] [Related]
26. High-affinity binding of the antiestrogen [3H]tamoxifen to the 8S estradiol receptor.
Capony F; Rochefort H
Mol Cell Endocrinol; 1978; 11(2):181-98. PubMed ID: 680340
[TBL] [Abstract][Full Text] [Related]
27. Binding of catechol estrogens to the estrogen receptor of dimethylbenz(A) anthracene induced rat mammary tumors.
Abul-Hajj YJ
J Steroid Biochem; 1980 Jan; 13(1):83-8. PubMed ID: 6770198
[No Abstract] [Full Text] [Related]
28. Early increases in ribonucleic acid polymerase activities of dimethylbenzanthracene-induced mammary tumour nuclei in response to oestradiol-17beta and tamoxifen.
Nicholson RI; Davies P; Griffiths K
J Endocrinol; 1977 Apr; 73(1):135-42. PubMed ID: 404379
[TBL] [Abstract][Full Text] [Related]
29. Influence of prenatal exposure to diethylstilbestrol on estrogen and progestin binding proteins in uteri and dimethylbenzanthracene- induced mammary tumors of the rat.
Heidemann PH; Wittliff JL; Calhoon RE; Boylan ES
J Toxicol Environ Health; 1981 Oct; 8(4):667-86. PubMed ID: 6802985
[TBL] [Abstract][Full Text] [Related]
30. Incidence, growth and oestradiol-receptor levels of 7, 12-dimethylbenz (alpha) anthracene-induced mammary tumours in rats: effects of neonatal sex steroids and oestradiol implants.
Verhoeven G; Vandoren G; Heyns W; Kühn ER; Janssens JP; Teuwen D; Goddeeris P; Lesaffre E; De Moor P
J Endocrinol; 1982 Dec; 95(3):357-68. PubMed ID: 6816889
[TBL] [Abstract][Full Text] [Related]
31. Purification of the cytoplasmic oestrogen receptor from mammary tumours induced in rats with dimethylbenzanthracene.
Al-Nuaimi N; Davies P; Griffiths K
J Endocrinol; 1979 Apr; 81(1):119-30. PubMed ID: 112212
[TBL] [Abstract][Full Text] [Related]
32. Biological activities of tamoxifen aziridine, an antiestrogen-based affinity label for the estrogen receptor, in vivo and in vitro.
Wei LL; Mangel WF; Katzenellenbogen BS
J Steroid Biochem; 1985 Dec; 23(6A):875-81. PubMed ID: 3937947
[TBL] [Abstract][Full Text] [Related]
33. Interactions of oestradiol-17beta and tamoxifen in the uterus of the pregnant rat.
Major JS; Green B; Heald PJ
J Endocrinol; 1976 Dec; 71(3):315-24. PubMed ID: 1003061
[TBL] [Abstract][Full Text] [Related]
34. The measurement of tamoxifen and metabolites in the rat and relationship to the response of DMBA-induced mammary tumours.
Daniel CP; Gaskell SJ; Nicholson RI
Eur J Cancer Clin Oncol; 1984 Jan; 20(1):137-43. PubMed ID: 6420159
[TBL] [Abstract][Full Text] [Related]
35. Antiestrogen binding sites in rat liver nuclei.
Kon OL
Biochim Biophys Acta; 1985 Dec; 843(3):245-53. PubMed ID: 4063396
[TBL] [Abstract][Full Text] [Related]
36. A simple modification of the estrogen receptor exchange assay: validation in nuclei from the rat uterus and a mouse mammary tumor.
Schoenberg DR; Clark JH
Endocrinology; 1980 Jan; 106(1):56-60. PubMed ID: 7349972
[TBL] [Abstract][Full Text] [Related]
37. Androgen effects mediated by estrogen receptor in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors.
Garcia M; Rochefort H
Cancer Res; 1978 Nov; 38(11 Pt 1):3922-9. PubMed ID: 100211
[No Abstract] [Full Text] [Related]
38. Nuclear binding of the estrogen receptor: heterogeneity of sites and uterotropic response.
Clark JH; Markaverich B; Upchurch S; Eriksson H; Hardin JW
Adv Exp Med Biol; 1979; 117():17-46. PubMed ID: 474276
[TBL] [Abstract][Full Text] [Related]
39. Unoccupied binding sites for oestradiol in nuclei from human breast carcinomatous tissue.
Geier A; Ginzburg R; Stauber M; Lunenfeld B
J Endocrinol; 1979 Mar; 80(3):281-8. PubMed ID: 438706
[TBL] [Abstract][Full Text] [Related]
40. Unfilled nuclear oestrogen receptors in the rat brain and pituitary gland.
Clark CR; MacLusky NJ; Naftolin F
J Endocrinol; 1982 Jun; 93(3):327-38. PubMed ID: 7086326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
